5-aminosalicylic acid analogues for treatment of irritable bowel syndrome

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of 5-ASA analogues for IBS in adults and children.

This is a protocol.

Health topics:

Gastroenterology & hepatology > Irritable bowel syndrome

Published:

9 September 2020

Authors:

Qin H-y, Yao L, Wang X, Wang Q, Tian J, Kwong JSW, Wu T, Zhao Xiang B

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Qin H-y, Yao L, Wang X, Wang Q, Tian J, Kwong JSW, Wu T, Zhao Xiang B. 5-aminosalicylic acid analogues for treatment of irritable bowel syndrome (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No.: CD013723. DOI: 10.1002/14651858.CD013723.